These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 16609034

  • 1. Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
    De Santis R, Albertoni C, Petronzelli F, Campo S, D'Alessio V, Rosi A, Anastasi AM, Lindstedt R, Caroni N, Arseni B, Chiodi P, Verdoliva A, Cassani G, Chinol M, Paganelli G, Carminati P.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2191-6. PubMed ID: 16609034
    [Abstract] [Full Text] [Related]

  • 2. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F, Pelliccia A, Anastasi AM, D'Alessio V, Albertoni C, Rosi A, Leoni B, De Angelis C, Paganelli G, Palombo G, Dani M, Carminati P, De Santis R.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [Abstract] [Full Text] [Related]

  • 3. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 01; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 4. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Hauck ML, Zalutsky MR.
    Int J Hyperthermia; 2005 Feb 01; 21(1):1-11. PubMed ID: 15764347
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I, Schoonooghe S, Cornelissen B, Blanckaert P, Coene E, Cuvelier C, Mertens N, Slegers G.
    Clin Cancer Res; 2005 Oct 15; 11(20):7288-96. PubMed ID: 16243799
    [Abstract] [Full Text] [Related]

  • 6. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic studies of mouse monoclonal antibodies to a rat colon carcinoma: I. Comparison of biodistribution in normal rats, syngeneic tumor-bearing rats, or tumor-bearing nude mice.
    Laborda J, Douillard JY, Burg C, Lizzio EF, Ridge J, Levenbook I, Hoffman T.
    J Nucl Med; 1990 Jun 15; 31(6):1028-34. PubMed ID: 2348232
    [Abstract] [Full Text] [Related]

  • 8. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
    Hauck ML, Dewhirst MW, Bigner DD, Zalutsky MR.
    Clin Cancer Res; 1997 Jan 15; 3(1):63-70. PubMed ID: 9815539
    [Abstract] [Full Text] [Related]

  • 9. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM, Karacay H, Richel H, McBride WJ, Rossi EA, Chang K, Yeldell D, Griffiths GL, Hansen HJ, Goldenberg DM.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 11. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW, Ullmann CD, Nieroda C, Qi CF, Eggensperger D, Shimada S, Steinberg SM, Schlom J.
    Cancer Res; 1993 Feb 01; 53(3):600-8. PubMed ID: 8425194
    [Abstract] [Full Text] [Related]

  • 12. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
    Rowlinson-Busza G, Bamias A, Krausz T, Epenetos AA.
    Cancer Res; 1991 Jun 15; 51(12):3251-6. PubMed ID: 2040000
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA.
    J Nucl Med; 2006 Jul 15; 47(7):1127-35. PubMed ID: 16818947
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of pre-irradiation on monoclonal antibody localization in colon tumor xenografts expressing a cell-associated antigen.
    Gridley DS, Slater JB, Slater JM.
    Anticancer Res; 1995 Jul 15; 15(1):99-104. PubMed ID: 7733650
    [Abstract] [Full Text] [Related]

  • 15. Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT).
    De Santis R, Anastasi AM, D'Alessio V, Pelliccia A, Albertoni C, Rosi A, Leoni B, Lindstedt R, Petronzelli F, Dani M, Verdoliva A, Ippolito A, Campanile N, Manfredi V, Esposito A, Cassani G, Chinol M, Paganelli G, Carminati P.
    Br J Cancer; 2003 Apr 07; 88(7):996-1003. PubMed ID: 12671694
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2005 Nov 07; 46(11):1907-15. PubMed ID: 16269606
    [Abstract] [Full Text] [Related]

  • 17. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K, Lee FT, Smyth FE, Power BE, Renner C, Brechbiel MW, Old LJ, Hudson PJ, Scott AM.
    Clin Cancer Res; 2001 Apr 07; 7(4):1061-72. PubMed ID: 11309358
    [Abstract] [Full Text] [Related]

  • 18. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
    Gestin JF, Loussouarn A, Bardiès M, Gautherot E, Gruaz-Guyon A, Saï-Maurel C, Barbet J, Curtet C, Chatal JF, Faivre-Chauvet A.
    J Nucl Med; 2001 Jan 07; 42(1):146-53. PubMed ID: 11197965
    [Abstract] [Full Text] [Related]

  • 19. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M, Larroque C, Langlois R, van Lier JE, Artus JC, Pèlegrin A.
    Photochem Photobiol; 1999 Dec 07; 70(6):930-6. PubMed ID: 10628305
    [Abstract] [Full Text] [Related]

  • 20. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, Tachibana M, Katsuoka Y, Dang NH, Morimoto C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.